相关实验视频
Updated: Sep 16, 2025

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
22.0K
阿司匹林与重组组织等离子体激活剂用于急性轻度中风:系统性审查和元分析
João Vitor Andrade Fernandes1, João Victor de Oliveira Ramos1, Maurus Marques de Almeida Holanda1
1Medical Sciences Center, Federal University of Paraíba, João Pessoa, Brazil.
Neurological research
|July 7, 2025
概括
对于轻微的缺血性中风,这项元分析发现阿司匹林和复合组织等离子体激活剂 (r-tPA) 提供了类似的恢复结果. 两种治疗都没有显示出残疾,死亡率或复发性中风率的显著差异.
科学领域:
- 神经学 神经学
- 心血管医学 心血管医学
- 临床试验 临床试验
背景情况:
- 轻度缺血性中风是一种常见的疾病,可能导致严重的残疾.
- 轻微缺血性中风的治疗决定是复杂的,平衡血栓溶解的潜在益处与出血风险.
研究的目的:
- 在急性轻度缺血性中风患者中,比较阿司匹林与静脉注射复合组织等离子体激活剂 (r-tPA) 的疗效和安全性.
- 评估结果,包括功能恢复,死亡率,复发性中风和出血.
主要方法:
- 在PubMed,Embase和Cochrane图书馆进行系统的文献搜索,截至2024年7月.
- 包括随机对照试验 (RCT) 和前性队列,比较阿司匹林和r-tPA.
- 使用随机效应模型对结果的聚合分析,包括修改的兰金尺度 (mRS) 评分,死亡率,复发性中风和症状出血.
主要成果:
- 在分析中包括了四项研究.
- 对于mRS 0-1或mRS 0-2的功能结果,在阿司匹林和r-tPA之间没有观察到显著的差异.
- 两种治疗方法在复发性中风或死亡率上都没有显著差异;阿司匹林趋向于降低症状出血风险.
结论:
- 阿司匹林和r-tPA在急性轻度缺血性中风的治疗中显示出可比的临床益处和类似的结果.
- 这些发现表明,治疗选择可能取决于个体患者的因素和风险概况,考虑到观察到的可比的疗效和安全性概况.
相关概念视频
Venous Thrombosis III: Interprofessional Care
26
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
26
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
652
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
652
Anticoagulant Drugs: Low-Molecular-Weight Heparins
919
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
919
Clot Retraction and Fibrinolysis
6.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.9K
Acute Coronary Syndrome IV: Interprofessional Care
32
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
46
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
46

